Literature DB >> 26338231

Pattern Recognition in Pharmacokinetic Data Analysis.

Johan Gabrielsson1, Bernd Meibohm2, Daniel Weiner3.   

Abstract

Pattern recognition is a key element in pharmacokinetic data analyses when first selecting a model to be regressed to data. We call this process going from data to insight and it is an important aspect of exploratory data analysis (EDA). But there are very few formal ways or strategies that scientists typically use when the experiment has been done and data collected. This report deals with identifying the properties of a kinetic model by dissecting the pattern that concentration-time data reveal. Pattern recognition is a pivotal activity when modeling kinetic data, because a rigorous strategy is essential for dissecting the determinants behind concentration-time courses. First, we extend a commonly used relationship for calculation of the number of potential model parameters by simultaneously utilizing all concentration-time courses. Then, a set of points to consider are proposed that specifically addresses exploratory data analyses, number of phases in the concentration-time course, baseline behavior, time delays, peak shifts with increasing doses, flip-flop phenomena, saturation, and other potential nonlinearities that an experienced eye catches in the data. Finally, we set up a series of equations related to the patterns. In other words, we look at what causes the shapes that make up the concentration-time course and propose a strategy to construct a model. By practicing pattern recognition, one can significantly improve the quality and timeliness of data analysis and model building. A consequence of this is a better understanding of the complete concentration-time profile.

Keywords:  absorption; area under the curve; bi-exponential; half-life; induction; intravenous and extravascular dosing; lag time; mono-exponential; multi-compartment; nonlinear elimination; plasma concentration-time courses; target-mediated drug disposition; transporters

Mesh:

Year:  2015        PMID: 26338231      PMCID: PMC4706292          DOI: 10.1208/s12248-015-9817-6

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  9 in total

1.  Within- and between-subject variations in pharmacokinetic parameters of ethanol by analysis of breath, venous blood and urine.

Authors:  A Norberg; J Gabrielsson; A W Jones; R G Hahn
Journal:  Br J Clin Pharmacol       Date:  2000-05       Impact factor: 4.335

Review 2.  Immunogenicity to therapeutic proteins: impact on PK/PD and efficacy.

Authors:  Narendra Chirmule; Vibha Jawa; Bernd Meibohm
Journal:  AAPS J       Date:  2012-03-10       Impact factor: 4.009

3.  Drug-drug interaction pattern recognition.

Authors:  John Z Duan
Journal:  Drugs R D       Date:  2010

4.  Misuse of the well-stirred model of hepatic drug clearance.

Authors:  Jiansong Yang; Masoud Jamei; Karen R Yeo; Amin Rostami-Hodjegan; Geoffrey T Tucker
Journal:  Drug Metab Dispos       Date:  2007-03       Impact factor: 3.922

5.  Time course of enzyme induction in humans: effect of pentobarbital on nortriptyline metabolism.

Authors:  C von Bahr; E Steiner; Y Koike; J Gabrielsson
Journal:  Clin Pharmacol Ther       Date:  1998-07       Impact factor: 6.875

Review 6.  Role of variability in explaining ethanol pharmacokinetics: research and forensic applications.

Authors:  Ake Norberg; A Wayne Jones; Robert G Hahn; Johan L Gabrielsson
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

7.  Pharmacokinetic evaluation of anticonvulsants prior to efficacy testing exemplified by carbamazepine in epileptic monkey model.

Authors:  J S Lockard; R H Levy; V Uhlir; J A Farquhar
Journal:  Epilepsia       Date:  1974-09       Impact factor: 5.864

8.  Parameter and structural identifiability concepts and ambiguities: a critical review and analysis.

Authors:  C Cobelli; J J DiStefano
Journal:  Am J Physiol       Date:  1980-07

9.  Dynamics of target-mediated drug disposition: characteristic profiles and parameter identification.

Authors:  Lambertus A Peletier; Johan Gabrielsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-08-01       Impact factor: 2.745

  9 in total
  6 in total

Review 1.  Pattern Recognition in Pharmacodynamic Data Analysis.

Authors:  Johan Gabrielsson; Stephan Hjorth
Journal:  AAPS J       Date:  2015-11-05       Impact factor: 4.009

2.  Modeling and Simulation of Pretomanid Pharmacokinetics in Pulmonary Tuberculosis Patients.

Authors:  Michael A Lyons
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

3.  Repeated KI Prophylaxis in Case of Prolonged Exposure to Iodine Radioisotopes: Pharmacokinetic Studies in Adult Rats.

Authors:  Guillaume Phan; Rym Chioukh; David Suhard; Alexandre Legrand; Charlotte Moulin; Thibaud Sontag; François Rebière; Céline Bouvier-Capely; Michelle Agarande; Valérie Renaud-Salis; Jean-René Jourdain
Journal:  Pharm Res       Date:  2018-10-08       Impact factor: 4.200

4.  The Use of Gene Ontology Term and KEGG Pathway Enrichment for Analysis of Drug Half-Life.

Authors:  Yu-Hang Zhang; Chen Chu; Shaopeng Wang; Lei Chen; Jing Lu; XiangYin Kong; Tao Huang; HaiPeng Li; Yu-Dong Cai
Journal:  PLoS One       Date:  2016-10-25       Impact factor: 3.240

5.  Comparative population pharmacokinetics and absolute oral bioavailability of COX-2 selective inhibitors celecoxib, mavacoxib and meloxicam in cockatiels (Nymphicus hollandicus).

Authors:  Laura Dhondt; Mathias Devreese; Siska Croubels; Siegrid De Baere; Roel Haesendonck; Tess Goessens; Ronette Gehring; Patrick De Backer; Gunther Antonissen
Journal:  Sci Rep       Date:  2017-09-25       Impact factor: 4.379

6.  In vivo and in silico characterization of apocynin in reducing organ oxidative stress: A pharmacokinetic and pharmacodynamic study.

Authors:  Fangfei Liu; Lampson M Fan; Nicholas Michael; Jian-Mei Li
Journal:  Pharmacol Res Perspect       Date:  2020-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.